Ross, LL;    Walker, AS;    Lou, Y;    Tenorio, AR;    Gibb, DM;    Double, J;    Gilks, C;                                         ... Shaefer, MS; + view all <#>        Ross, LL;  Walker, AS;  Lou, Y;  Tenorio, AR;  Gibb, DM;  Double, J;  Gilks, C;  McCoig, CC;  Munderi, P;  Musoro, G;  Kityo, CM;  Grosskurth, H;  Hakim, J;  Mugyenyi, PN;  Cutrell, A;  Perger, T;  Shaefer, MS;   - view fewer <#>    (2019)    Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min.                   PLoS One , 14  (11)    , Article e0225199.  10.1371/journal.pone.0225199 <https://doi.org/10.1371/journal.pone.0225199>.       Green open access